Palatin Technologies (FRA:PTN) Research & Development: €10.59 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:PTN Palatin Technologies Inc FRA:PTN
19 GF Score
Price €3.30
! 5 Warning Signs
View Full Analysis

What is Palatin Technologies Research & Development?

Palatin Technologies FRA:PTN 19 Research & Development is €10.59 Mil as of Mar. 2026. GuruFocus rates FRA:PTN with a GF Score™ of 19/100. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Palatin Technologies's Research & Development for the three months ended in Mar. 2026 was €3.04 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €10.59 Mil.

Palatin Technologies  (FRA:PTN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Palatin Technologies Research & Development Related Terms

Palatin Technologies Research & Development Historical Data

* Premium members only.

The historical data trend for Palatin Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Palatin Technologies Research & Development Chart

Palatin Technologies Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.73 20.18 20.89 20.81 12.92

Palatin Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.47 1.71 2.15 3.69 3.04
FRA:PTN
19GF Score
Palatin Technologies Inc FRA:PTN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Palatin Technologies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €10.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €10.59 Mil mean?
Palatin Technologies (FRA:PTN) has a Research & Development of €10.59 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Palatin Technologies and its competitors.
Is Palatin Technologies' Research & Development too high?
Palatin Technologies' current Research & Development is €10.59 Mil. Overall, Palatin Technologies has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Palatin Technologies' Research & Development compare to LPCN and NCEL?
Palatin Technologies' Research & Development of €10.59 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Palatin Technologies and its competitors. Palatin Technologies's current Research & Development is €10.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Palatin Technologies stock overvalued right now?
Palatin Technologies (FRA:PTN) has a current Research & Development of €10.59 Mil. The current Research & Development is €10.59 Mil. Palatin Technologies' overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Palatin Technologies (FRA:PTN), the current Research & Development is €10.59 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Palatin Technologies Business Description

Other Exchanges PTN:USA0KF3:UK
Address 103 Carnegie Center Drive, Suite 300, Princeton, NJ, USA, 08852
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.
19GF Score

Get the complete analysis for FRA:PTN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.30
Price